Abbott CEO Robert B. Ford disposes of $ US 46.17 million in common shares

• Abbott Laboratories Chairman and CEO Robert B. Ford reported option exercises, acquiring 398,832 common shares on Aug. 25, 2026.
• Exercises were priced at $44.4 and $59.94 per share.
• He also sold 398,832 common shares the same day at weighted-average prices of $115.57 and $116.19.
• Directly held common shares totaled 306,461 after the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001612571-26-000011), on August 27, 2026, and is solely responsible for the information contained therein.